Lines of therapy before autologous stem cell transplant and CAR-T affect outcomes in aggressive Non-Hodgkin's lymphoma

被引：5

作者：

Khurana, Arushi ^{[1
]}

Hathcock, Matthew ^{[1
]}

Habermann, Thomas M. ^{[1
]}

Al Saleh, Abdullah S. ^{[2
]}

Gandhi, Sangeetha ^{[1
]}

Truong, Tuan ^{[1
]}

Bennani, N. Nora ^{[1
]}

Paludo, Jonas ^{[1
]}

Villasboas, Jose C. ^{[1
]}

Ansell, Stephen M. ^{[1
]}

Inwards, David J. ^{[1
]}

Porrata, Luis F. ^{[1
]}

Johnston, Patrick B. ^{[1
]}

Micallef, Ivana ^{[1
]}

Lin, Yi ^{[1
]}

机构：

[1] Mayo Clin, Div Hematol, Rochester, MN USA

[2] King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 10期

关键词：

D O I：

10.1002/ajh.26293

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E386 / E389

页数：4

共 8 条

[1] Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study [J].

Abramson, Jeremy S. ;

Palomba, M. Lia ;

Gordon, Leo I. ;

Lunning, Matthew A. ;

Wang, Michael ;

Arnason, Jon ;

Mehta, Amitkumar ;

Purev, Enkhtsetseg ;

Maloney, David G. ;

Andreadis, Charalambos ;

Sehgal, Alison ;

Solomon, Scott R. ;

Ghosh, Nilanjan ;

Albertson, Tina M. ;

Garcia, Jacob ;

Kostic, Ana ;

Mallaney, Mary ;

Ogasawara, Ken ;

Newhall, Kathryn ;

Kim, Yeonhee ;

Li, Daniel ;

Siddiqi, Tanya .

LANCET, 2020, 396 (10254) :839-852

[2] Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma [J].

Locke, Frederick L. ;

Rossi, John M. ;

Neelapu, Sattva S. ;

Jacobson, Caron A. ;

Miklos, David B. ;

Ghobadi, Armin ;

Oluwole, Olalekan O. ;

Reagan, Patrick M. ;

Lekakis, Lazaros J. ;

Lin, Yi ;

Sherman, Marika ;

Better, Marc ;

Go, William Y. ;

Wiezorek, Jeffrey S. ;

Xue, Allen ;

Bot, Adrian .

BLOOD ADVANCES, 2020, 4 (19) :4898-4911

[3] Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium [J].

Nastoupil, Loretta J. ;

Jain, Michael D. ;

Feng, Lei ;

Spiegel, Jay Y. ;

Ghobadi, Armin ;

Lin, Yi ;

Dahiya, Saurabh ;

Lunning, Matthew ;

Lekakis, Lazaros ;

Reagan, Patrick ;

Oluwole, Olalekan ;

McGuirk, Joseph ;

Deol, Abhinav ;

Sehgal, Alison R. ;

Goy, Andre ;

Hill, Brian T. ;

Vu, Khoan ;

Andreadis, Charalambos ;

Munoz, Javier ;

Westin, Jason ;

Chavez, Julio C. ;

Cashen, Amanda ;

Bennani, N. Nora ;

Rapoport, Aaron P. ;

Vose, Julie M. ;

Miklos, David B. ;

Neelapu, Sattva S. ;

Locke, Frederick L. .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (27) :3119-+

[4] Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma [J].

Neelapu, S. S. ;

Locke, F. L. ;

Bartlett, N. L. ;

Lekakis, L. J. ;

Miklos, D. B. ;

Jacobson, C. A. ;

Braunschweig, I. ;

Oluwole, O. O. ;

Siddiqi, T. ;

Lin, Y. ;

Timmerman, J. M. ;

Stiff, P. J. ;

Friedberg, J. W. ;

Flinn, I. W. ;

Goy, A. ;

Hill, B. T. ;

Smith, M. R. ;

Deol, A. ;

Farooq, U. ;

McSweeney, P. ;

Munoz, J. ;

Avivi, I. ;

Castro, J. E. ;

Westin, J. R. ;

Chavez, J. C. ;

Ghobadi, A. ;

Komanduri, K. V. ;

Levy, R. ;

Jacobsen, E. D. ;

Witzig, T. E. ;

Reagan, P. ;

Bot, A. ;

Rossi, J. ;

Navale, L. ;

Jiang, Y. ;

Aycock, J. ;

Elias, M. ;

Chang, D. ;

Wiezorek, J. ;

Go, W. Y. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26) :2531-2544

[5] A Multicenter Retrospective Analysis of Clinical Outcomes, Toxicities, and Patterns of Use in Institutions Utilizing Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B-Cell Lymphomas [J].

Riedell, Peter A. ;

Walling, Chase ;

Nastoupil, Loretta J. ;

Pennisi, Martina ;

Maziarz, Richard T. ;

McGuirk, Joseph P. ;

Oluwole, Olalekan O. ;

Bachanova, Veronika ;

Hwang, Wei-Ting ;

Schuster, Stephen J. ;

Perales, Miguel-Angel ;

Bishop, Michael R. ;

Porter, David L. .

BLOOD, 2019, 134

[6] Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas [J].

Schuster, Stephen J. ;

Svoboda, Jakub ;

Chong, Elise A. ;

Nasta, Sunita D. ;

Mato, Anthony R. ;

Anak, Ozlem ;

Brogdon, Jennifer L. ;

Pruteanu-Malinici, Iulian ;

Bhoj, Vijay ;

Landsburg, Daniel ;

Wasik, Mariusz ;

Levine, Bruce L. ;

Lacey, Simon F. ;

Melenhorst, Jan J. ;

Porter, David L. ;

June, Carl H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26) :2545-2554

[7] Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies [J].

Sermer, David ;

Batlevi, Connie ;

Palomba, M. Lia ;

Shah, Gunjan ;

Lin, Richard J. ;

Perales, Miguel-Angel ;

Scordo, Michael ;

Dahi, Parastoo ;

Pennisi, Martina ;

Afuye, Aishat ;

Silverberg, Mari Lynne ;

Ho, Caleb ;

Flynn, Jessica ;

Devlin, Sean ;

Caron, Philip ;

Hamilton, Audrey ;

Hamlin, Paul ;

Horwitz, Steven ;

Joffe, Erel ;

Kumar, Anita ;

Matasar, Matthew ;

Noy, Ariela ;

Owens, Colette ;

Moskowitz, Alison ;

Straus, David ;

von Keudell, Gottfried ;

Rodriguez-Rivera, Ildefonso ;

Falchi, Lorenzo ;

Zelenetz, Andrew ;

Yahalom, Joachim ;

Younes, Anas ;

Sauter, Craig .

BLOOD ADVANCES, 2020, 4 (19) :4669-4678

[8]

Tully Stephen, 2019, JCO Clin Cancer Inform, V3, P1, DOI 10.1200/CCI.19.00086

← 1 →